Considerations in the extrapolation of drug toxicity between humans and dogs

Bailey, 2013, An analysis of the use of dogs in predicting human toxicology and drug safety, Altern Lab Anim, 41, 335, 10.1177/026119291304100504 van Meer, 2012, The ability of animal studies to detect serious post marketing adverse events is limited, Regul Toxicol Pharmacol, 64, 345, 10.1016/j.yrtph.2012.09.002 Prior, 2019, Integration of consortia recommendations for justification of animal use within current and future drug development paradigms, Int J Toxicol, 38, 319, 10.1177/1091581819852922 Bailey, 2019, Recent efforts to elucidate the scientific validity of animal-based drug tests by the pharmaceutical industry, pro-testing lobby groups, and animal welfare organisations, BMC Med Ethics, 20, 10.1186/s12910-019-0352-3 Clark, 2015, Prediction of clinical risks by analysis of preclinical and clinical adverse events, J Biomed Inf, 54, 167, 10.1016/j.jbi.2015.02.008 Boulay, 2019, A proof-of-concept evaluation of JTPc and Tp-Tec as proarrhythmia biomarkers in preclinical species: a retrospective analysis by an HESI-sponsored consortium, Int J Toxicol, 38, 23, 10.1177/1091581818813601 Monticello, 2017, Current nonclinical testing paradigm enables safe entry to First-In-Human clinical trials: the IQ consortium nonclinical to clinical translational database, Toxicol Appl Pharmacol, 334, 100, 10.1016/j.taap.2017.09.006 Jetter, 2019, Drugs and hepatic transporters: a review, Pharmacol Res, Apr, 17, 104234 Dong, 2018, Cytochrome P450 genotype-guided drug therapies: an update on current states, Clin Exp Pharmacol Physiol, 45, 991, 10.1111/1440-1681.12978 Martinez, 2018, Population variability in animal health: influence on dose-exposure-response relationships: Part I: drug metabolism and transporter systems, J Vet Pharmacol Therapeut, 41, E57, 10.1111/jvp.12670 https://vcahospitals.com/know-your-pet/chocolate-poisoning-in-dogs Accessed 08-07-2020. https://www.merckvetmanual.com/toxicology/food-hazards/chocolate Accessed 08-07-2020. https://pets.webmd.com/dogs/ss/slideshow-foods-your-dog-should-never-eat Accessed 08-07-2020. Kovalkovičová, 2009, Some food toxic for pets, Interdiscipl Toxicol, 2, 169, 10.2478/v10102-009-0012-4 https://wagwalking.com/condition/lemon-and-lime-poisoning#causes Accessed 08-07-2020. https://www.webvets.com/Resources/resource.php?Grape-and-Raisin-Toxicity-by-Frank-Utchen-DVM-64 Accessed 08-08-2020. https://www.dogster.com/dog-health-care/can-dogs-eat-nuts Accessed 08-07-2020. https://dogtime.com/dog-health/dog-food-dog-nutrition/84028-can-dogs-drink-milk Accessed 08-07-2020. http://www.raw-food-health.net/Onion-Toxicity.html Accessed 08-07-2020. https://www.petpoisonhelpline.com/pet-owners/basics/top-10-human-medications-poisonous-to-pets/Accessed 08-07-2020. Hanioka, 2019, Hydrolysis of di(2-ethylhexyl) phthalate in humans, monkeys, dogs, rats, and mice: an in vitro analysis using liver and intestinal microsomes, Toxicol Vitro, 54, 237, 10.1016/j.tiv.2018.10.006 Timchalk, 2004, Comparative inter-species pharmacokinetics of phenoxyacetic acid herbicides and related organic acids. evidence that the dog is not a relevant species for evaluation of human health risk, Toxicology, 200, 1, 10.1016/j.tox.2004.03.005 Chen, 2009, Co-induction of CYP3A12 and 3A26 in dog liver slices by xenobiotics: species difference between human and dog CYP3A induction, Drug Metabol Lett, 3, 61, 10.2174/187231209787176399 Heikkinen, 2015, Quantitative ADME proteomics – CYP and UGT enzymes in the beagle dog liver and intestine, Pharm Res (N Y), 32, 74, 10.1007/s11095-014-1446-8 Martinez, 2019, Absolute quantitation of drug-metabolizing cytochrome P450 enzymes and accessory proteins in dog liver microsomes using label-free standard-free analysis reveals interbreed variability, Drug Metab Dispos, 47, 1314, 10.1124/dmd.119.088070 Ramirez, 2019, Kinetics of cyclophosphamide metabolism in humans, dogs, cats, and mice and relationship to cytotoxic activity and pharmacokinetics, Drug Metab Dispos, 47, 257, 10.1124/dmd.118.083766 Dalgaard, 2015, Comparison of minipig, dog, monkey and human drug metabolism and disposition, J Pharmacol Toxicol Methods, 74, 80, 10.1016/j.vascn.2014.12.005 Paine, 2006, The human intestinal cytochrome P450 "pie, Drug Metab Dispos, 34, 880, 10.1124/dmd.105.008672 Ho, 2017, Human enterocytes as an in vitro model for the evaluation of intestinal drug metabolism: characterization of drug-metabolizing enzyme activities of cryopreserved human enterocytes from twenty-four donors, Drug Metab Dispos, 45, 686, 10.1124/dmd.116.074377 Lai, 2009, Identification of interspecies difference in hepatobiliary transporters to improve extrapolation of human biliary secretion, Expet Opin Drug Metabol Toxicol, 5, 1175, 10.1517/17425250903127234 Berry, 2011, Species differences in distribution and prediction of human V(ss) from preclinical data, Drug Metab Dispos, 39, 2103, 10.1124/dmd.111.040766 Matsunaga, 2019, Hepatic organic anion transporting polypeptide-mediated clearance in the beagle dog: assessing in vitro-in vivo relationships and applying cross-species empirical scaling factors to improve prediction of human clearance, Drug Metab Dispos, 47, 215, 10.1124/dmd.118.084194 Basit, 2019, Kidney cortical transporter expression across species using quantitative proteomics, Drug Metab Dispos, 47, 802, 10.1124/dmd.119.086579 Wittenburg, 2019, Simultaneous absolute quantitation of ATP-binding cassette transporters in normal dog tissues by signature peptide analysis using a LC/MS/MS method, Res Vet Sci, 122, 93, 10.1016/j.rvsc.2018.11.009 Wilby, 2011, Hepatic uptake in the dog: comparison of uptake in hepatocytes and human embryonic kidney cells expressing dog organic anion-transporting polypeptide 1B4, Drug Metab Dispos, 39, 2361, 10.1124/dmd.111.041814 Zou, 2018, Molecular mechanisms for species differences in organic anion transporter 1, OAT1: implications for renal drug toxicity, Mol Pharmacol, 94, 689, 10.1124/mol.117.111153 Kelly, 2015, Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders, Front Cell Neurosci, 14, 392 Coelho, 2018, Similarity of the dog and human gut microbiomes in gene content and response to diet, Microbiome, 1, 72, 10.1186/s40168-018-0450-3 Barko, 2018, The gastrointestinal microbiome: a review, J Vet Intern Med, 1, 9, 10.1111/jvim.14875 Chan, 2018, Comparing Mechanistic and Preclinical [redictions of volume of distribution on a large set of drugs, Pharm Res (N Y), 4, 87, 10.1007/s11095-018-2360-2 Ruark, 2014, Predicting passive and active tissue:plasma partition coefficients: interindividual and interspecies variability, J Pharm Sci, 7, 2189, 10.1002/jps.24011 Ramaswamy, 1999, Species differences in the proportion of plasma lipoprotein lipid carried by high-density lipoproteins influence the distribution of free and liposomal nystatin in human, dog, and rat plasma, Antimicrob Agents Chemother, 6, 1424, 10.1128/AAC.43.6.1424 Di, 2011, Species independence in brain tissue binding using brain homogenates, Drug Metab Dispos, 7, 1270, 10.1124/dmd.111.038778 Craven, 2011, The risky business of drug development in neurology, Lancet Neurol, 2, 116, 10.1016/S1474-4422(11)70004-7 Hutchinson, 2011, High drug attrition rates--where are we going wrong?, Nat Rev Clin Oncol, 4, 189, 10.1038/nrclinonc.2011.34 Danhof, 1984, Kinetics of drug action in disease states. II. Effect of experimental renal dysfunction on phenobarbital concentrations in rats at onset of loss of righting reflect, J Pharmacol Exp Therapeut, 230, 627 Danhof, 1985, Kinetics of drug action in disease states XII: effect of experimental liver diseases on the pharmacodynamics of phenobarbital and ethanol in rats, J Pharm Sci, 3, 321, 10.1002/jps.2600740320 Hisaoka, 1985, Kinetics of drug action in disease states. XIII, Effect of dialyzable component(s) of uremic blood on phenobarbital concentrations in rats at onset of loss of righting reflex, J Pharmacol Exp Therapeut, 1, 180 Walker, 1989, Kinetics of drug action in disease states. XXXII: effect of experimental hypertension on the pharmacodynamics of phenobarbital in rats, J Pharm Sci, 9, 742, 10.1002/jps.2600780908 Schneider, 2018, Model-based reverse translation between veterinary and human medicine: the One Health Initiative, CPT Pharmacometrics Syst Pharmacol, 2, 65, 10.1002/psp4.12262 McConn, 2009, Reduced duodenal cytochrome P450 3A protein expression and catalytic activity in patients with cirrhosis, Clin Pharmacol Ther, 4, 387, 10.1038/clpt.2008.292 Johnson, 2010, A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance, Clin Pharmacokinet, 49, 189, 10.2165/11318160-000000000-00000 Rowland Yeo, 2011, Modeling and predicting drug pharmacokinetics in patients with renal impairment, Expet Rev Clin Pharmacol, 4, 261, 10.1586/ecp.10.143 Schütt, 2016, Dogs with cognitive dysfunction as a spontaneous model for early Alzheimer's Disease: a translational study of neuropathological and inflammatory markers, J Alzheimers Dis, 52, 433, 10.3233/JAD-151085 Ambrosini, 2019, The gut-brain axis in neurodegenerative diseases and relevance of the canine model: a review, Front Aging Neurosci, 11, 130, 10.3389/fnagi.2019.00130 Mochel, 2019, Cell Immunotherapy in human and veterinary oncology: changing the odds against hematological malignancies, AAPS J, 21, 50, 10.1208/s12248-019-0322-1 Gordon, 2009, The Comparative Oncology Trials Consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway, PLoS Med, 6, 10.1371/journal.pmed.1000161 Lu, 2017, Crypt organoid culture as an in vitro model in drug metabolism and cytotoxicity studies, Drug Metab Dispos, 45, 748, 10.1124/dmd.117.075945 Mochel, 2017, Intestinal stem cells to advance drug development, precision, and regenerative medicine: a paradigm shift in translational research, AAPS J, 20, 17, 10.1208/s12248-017-0178-1 Kingsbury, 2018, Comparison of endoscopically (Egd/Colo) procured enteroids and colonoids from normal dogs and dogs with naturally occurring chronic enteropathies (IBD), Gastroenterol, 154, S686, 10.1016/S0016-5085(18)32420-X Chandra, 2019, Derivation of adult canine intestinal organoids for translational research in gastroenterology, BMC Biol, 17, 33, 10.1186/s12915-019-0652-6 Musther, 2014, Animal versus human oral drug bioavailability: do they correlate?, Eur J Pharmaceut Sci, 16, 280, 10.1016/j.ejps.2013.08.018 Thiel, 2015, A systematic evaluation of the use of physiologically based pharmacokinetic modeling for cross-species extrapolation, J Pharm Sci, 104, 191, 10.1002/jps.24214 Rostami-Hodjegan, 2012, Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology, Clin Pharmacol Ther, 92, 50, 10.1038/clpt.2012.65 Pierrillas, 2019, Prediction of human nonlinear pharmacokinetics of a new Bcl-2 inhibitor using PBPK modeling and interspecies extrapolation strategy, Drug Metab Dispos, 47, 648, 10.1124/dmd.118.085605 Sinha, 2012, From preclinical to human--prediction of oral absorption and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: a workflow by using case example, Biopharm Drug Dispos, 33, 111, 10.1002/bdd.1782 Landis, 2018, Commentary: Why pharmaceutical scientists in early drug discovery are critical for influencing the design and selection of optimal drug candidates, AAPS PharmSciTech, 19, 1, 10.1208/s12249-017-0849-3 Pade, 2017, Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon, Biopharm Drug Dispos, 38, 94, 10.1002/bdd.2072 Shida, 2016, Human plasma concentrations of five cytochrome P450 probes extrapolated from pharmacokinetics in dogs and minipigs using physiologically based pharmacokinetic modeling, Xenobiotica, 46, 759, 10.3109/00498254.2015.1118650